Search - tctmd.com

Displaying 1 - 2 of 2

Sort: Relevancy | Date

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

December 28, 2021

Amyloid Beta (1-40) Shows Promise as a Blood Marker to Risk Stratify NSTE ACS Patients

News Daily News

Amyloid Beta (1-40) Shows Promise as a Blood Marker to Risk Stratify NSTE ACS Patients

May 21, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.